ES2408932T3 - Síntesis y uso de agentes antibacterianos heterocíclicos - Google Patents

Síntesis y uso de agentes antibacterianos heterocíclicos Download PDF

Info

Publication number
ES2408932T3
ES2408932T3 ES09770902T ES09770902T ES2408932T3 ES 2408932 T3 ES2408932 T3 ES 2408932T3 ES 09770902 T ES09770902 T ES 09770902T ES 09770902 T ES09770902 T ES 09770902T ES 2408932 T3 ES2408932 T3 ES 2408932T3
Authority
ES
Spain
Prior art keywords
phenyl
compound
substituted
formula
ethynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09770902T
Other languages
English (en)
Spanish (es)
Inventor
Panduranga Adulla P. Reddy
Umar Faruk Mansoor
M. Arshad Siddiqui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme Ltd
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd, Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2408932T3 publication Critical patent/ES2408932T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
ES09770902T 2008-06-25 2009-06-24 Síntesis y uso de agentes antibacterianos heterocíclicos Active ES2408932T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7538308P 2008-06-25 2008-06-25
US75383 2008-06-25
PCT/US2009/048368 WO2009158369A1 (en) 2008-06-25 2009-06-24 Synthesis and use of heterocyclic antibacterial agents

Publications (1)

Publication Number Publication Date
ES2408932T3 true ES2408932T3 (es) 2013-06-24

Family

ID=41059643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09770902T Active ES2408932T3 (es) 2008-06-25 2009-06-24 Síntesis y uso de agentes antibacterianos heterocíclicos

Country Status (6)

Country Link
US (1) US20110212078A1 (https=)
EP (1) EP2307365B1 (https=)
JP (1) JP2011525927A (https=)
CA (1) CA2728210A1 (https=)
ES (1) ES2408932T3 (https=)
WO (1) WO2009158369A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519508B (zh) 2007-06-12 2016-02-01 Achaogen Inc 抗菌劑
WO2012031298A2 (en) 2010-09-03 2012-03-08 Duke University Ethynylbenzene derivatives
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
WO2015024016A2 (en) 2013-08-16 2015-02-19 Duke University 2-piperidinyl substituted n,3-dihydroxybutanamides
WO2015024021A2 (en) 2013-08-16 2015-02-19 Duke University Antibacterial compounds
US10647664B2 (en) 2013-08-16 2020-05-12 Duke University Substituted hydroxamic acid compounds
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
US10011611B2 (en) 2015-08-14 2018-07-03 Reaction Biology Corp. Histone deacetylase inhibitors and methods for use thereof
AR108864A1 (es) 2016-06-23 2018-10-03 Achaogen Inc Agentes antibacterianos
GB2562777A (en) * 2017-05-25 2018-11-28 Taisho Pharmaceutical Co Ltd Novel alpha-amino amide derivatives
UA126452C2 (uk) * 2017-06-02 2022-10-05 Ф. Хоффманн-Ля Рош Аг Похідні ізоіндолу
WO2018220149A1 (en) 2017-06-02 2018-12-06 F. Hoffmann-La Roche Ag Compounds
PE20211388A1 (es) 2018-06-29 2021-07-27 Hoffmann La Roche Compuestos
IL288522B2 (en) 2019-06-21 2025-02-01 Hoffmann La Roche EGFR inhibitor for cancer treatment
MA56507A (fr) 2019-06-21 2022-04-27 Hoffmann La Roche Nouveaux inhibiteurs d'egfr
CN110498783A (zh) * 2019-08-02 2019-11-26 成都蓝蜻蜓生物技术有限公司 一种合成罗沙司他中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925659A (en) 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
WO1999041246A1 (en) 1998-02-11 1999-08-19 Du Pont Pharmaceuticals Company Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
AU748887B2 (en) 1998-02-12 2002-06-13 Myriad Genetics, Inc. Beta-sheet mimetics and methods relating to the use thereof
JP4020290B2 (ja) * 2000-09-14 2007-12-12 独立行政法人科学技術振興機構 光学活性ヒドロキサム酸
DE10227464A1 (de) 2002-06-20 2004-01-08 Technische Universität Braunschweig Glaszusammensetzung zur Herstellung von optischen Übertragungselementen
KR101076018B1 (ko) 2003-01-08 2011-10-21 유니버시티 오브 워싱톤 항균제
KR20080070876A (ko) 2005-12-01 2008-07-31 쉐링 코포레이션 염증 질환 및 미생물 질병 치료용 조성물
WO2008027466A1 (en) 2006-08-31 2008-03-06 Schering Corporation Hydantoin derivatives useful as antibacterial agents
TWI519508B (zh) * 2007-06-12 2016-02-01 Achaogen Inc 抗菌劑

Also Published As

Publication number Publication date
EP2307365B1 (en) 2013-03-27
JP2011525927A (ja) 2011-09-29
CA2728210A1 (en) 2009-12-30
US20110212078A1 (en) 2011-09-01
EP2307365A1 (en) 2011-04-13
WO2009158369A1 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
ES2408932T3 (es) Síntesis y uso de agentes antibacterianos heterocíclicos
EP2057127B1 (en) Hydantoin derivatives useful as antibacterial agents
US20110212080A1 (en) Urea derivatives as antibacterial agents
ES2924522T3 (es) Inhibidores heteroarilo de PAD4
EP0303697B1 (en) Derivatives of physiologically active substance k-252
CN110770242B (zh) 作为vanin抑制剂的杂芳族化合物
CN115835866B (zh) Cereblon结合化合物、其组合物及其用于治疗的方法
PT931063E (pt) Indol-3-glioxilamidas n-substituídas com efeito anti-asmático, anti-alérgico e imunossupressor/imunomodulador
ES2881681T3 (es) 3,4-Dihidro-1H-[1,8]naftiridinonas sustituidas con piperidinilo antibacterianas
CN102482219A (zh) 吡喃酮和吡啶酮衍生物的制备方法
BRPI0719861A2 (pt) Compostos heteroaromáticos bicíclicos
CA2632921A1 (en) Compounds for the treatment of inflammatory disorders and microbial diseases
TW200906401A (en) Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
ES2776145T3 (es) 3,4-Dihidro-1h-[1,8]naftiridinonas sustituidas con homopiperidinilo antibacterianas
JP6434528B2 (ja) 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用
ES2303532T3 (es) Nuevos derivados de indol y su uso como medicamentos.
US5574039A (en) Antiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituents
KR20100132553A (ko) 신규한 ｎ-(2-아미노-페닐)-아크릴아미드
ES2251234T3 (es) Nuevos derivados de pirimidina y proceso para su preparacion.
ES2981840T3 (es) Derivados de isoquinolina para su uso en el tratamiento del síndrome de deficiencia de GLUT1
US7750049B2 (en) O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists
DK164787B (da) 3-substituerede pyrazolooe1,5-aaapyridinderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
JP2018517720A (ja) 新規ホスホジエステラーゼ５阻害剤とその使用
CS214797B2 (cs) Způsob výroby nových derivátů 4-amino-2-piperidinochinazolinu
JPH0812672A (ja) チアジアジノン誘導体